Watchful waiting and health related quality of life for patients with localized prostate cancer: Data from CaPSURE

被引:38
作者
Arredondo, SA
Downs, TM
Lubeck, DP
Pasta, DJ
Silva, SJ
Wallace, KL
Carroll, PR
机构
[1] Univ Calif San Francisco, Ctr Comprehens Canc, Urol Outcomes Res Grp, Dept Urol, San Francisco, CA USA
[2] TAP Pharmaceut Prod Inc, Lake Forest, IL USA
关键词
quality of life; prostatic neoplasms; outcome assessment;
D O I
10.1097/01.ju.0000140758.04424.77
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Watchful waiting is an alternative to active treatment for men with low risk prostate cancer but it is unclear how health related quality of life (HRQoL) may change over time for men who select this option. We report on HRQoL in men with localized prostate cancer who selected watchful waiting. Materials and Methods: HRQoL outcomes were reviewed for 310 men diagnosed with prostate cancer from 1990 to 2001 within Cancer of the Prostate Strategic Urological Research Endeavor who chose watchful waiting. The UCLA Prostate Cancer Index and RAND 36-Item Health Survey were completed at enrollment and approximately every 6 months. A random slopes model was developed to assess time trends in HRQoL for up to 5 years after diagnosis, adjusting for age at diagnosis and specific comorbidities. Results: Significant decreases with time were observed in 7 domains of the RAND 36-Item Health Survey and 4 of the UCLA Prostate Cancer Index scales. Conclusions: Men with prostate cancer who chose watchful waiting in the current study had better or similar HRQoL outcomes compared to men without prostate cancer at the start of the study. Many of these scores were significantly affected by increasing age and decreased with time. The physical domain scores as well as sexual function scores decreased more than expected from the aging process alone.
引用
收藏
页码:1830 / 1834
页数:5
相关论文
共 15 条
[1]  
[Anonymous], CANC FACTS FIG 2003
[2]   The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer [J].
Bacon, CG ;
Giovannucci, E ;
Testa, M ;
Kawachi, I .
JOURNAL OF UROLOGY, 2001, 166 (05) :1804-1810
[3]  
Galbraith M E, 2001, Oncol Nurs Forum, V28, P551
[4]   Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: Results from CaPSURE [J].
Harlan, SR ;
Cooperberg, MR ;
Elkin, EP ;
Lubeck, DP ;
Meng, MV ;
Mehta, SS ;
Carroll, PR .
JOURNAL OF UROLOGY, 2003, 170 (05) :1804-1807
[5]   MEASUREMENT OF HEALTH-STATUS - ASCERTAINING THE MINIMAL CLINICALLY IMPORTANT DIFFERENCE [J].
JAESCHKE, R ;
SINGER, J ;
GUYATT, GH .
CONTROLLED CLINICAL TRIALS, 1989, 10 (04) :407-415
[6]  
Jonler M, 1998, UROLOGY, V52, P1055, DOI 10.1016/S0090-4295(98)00449-X
[7]   The UCLA Prostate Cancer Index - Development, reliability, and validity of a health-related quality of life measure [J].
Litwin, MS ;
Hays, RD ;
Fink, A ;
Ganz, PA ;
Leake, B ;
Brook, RH .
MEDICAL CARE, 1998, 36 (07) :1002-1012
[8]   Health related quality of life in older men without prostate cancer [J].
Litwin, MS .
JOURNAL OF UROLOGY, 1999, 161 (04) :1180-1184
[9]   Mental health in men treated for early stage prostate carcinoma -: A posttreatment, longitudinal quality of life analysis from the cancer of the prostate strategic urologic research endeavor™ [J].
Litwin, MS ;
Lubeck, DP ;
Spitalny, GM ;
Henning, JM ;
Carroll, PR .
CANCER, 2002, 95 (01) :54-60
[10]   QUALITY-OF-LIFE OUTCOMES IN MEN FOR LOCALIZED PROSTATE-CANCER [J].
LITWIN, MS ;
HAYS, RD ;
FINK, A ;
GANZ, PA ;
LEAKE, B ;
LEACH, GE ;
BROOK, RH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (02) :129-135